Junwei Shi

14.7k citations
95 papers · 10.9k · 6 hit papers · h-index 41

Impact in

    • Protein Degradation and Inhibitors
    • Genomics and Chromatin Dynamics
    • CRISPR and Genetic Engineering
    • Epigenetics and DNA Methylation
    • RNA modifications and cancer
    • Chromatin Remodeling and Cancer
  • Hematology top 1%
    • Acute Myeloid Leukemia Research

Papers in

    • Hemoglobinopathies and Related Disorders 14
    • Acute Myeloid Leukemia Research 15

Junwei Shi

91 papers receiving 10.8k citations

Junwei Shi's Hit Papers

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control 2017 · 901 citations
9010+5+10Years since publication5001k1.5k2k

Peers

Junwei Shi
Comparison fields: 5 of 107
  • Molecular Biology 6.9k
  • Hematology 1.1k
  • Oncology 1.4k
  • Genetics 518
  • Cancer Research 523
Replace Irmela Jeremias with:
Irmela Jeremias Germany
Peter G. Smith United States
Vivian R. Ruvolo United States
Markus Müschen United States
Yutaka Kondo Japan
Ruth W. Craig United States
Jamie I. Fletcher Australia
Stuart A. Aaronson United States
Takaomi Sanda United States
Mark Rolfe United States
Junwei Shi relative to Irmela Jeremias Germany Irmela Jeremias's profile →
Citations per field
00.5×2×3×3.7×
Irmela Jeremias · 1×
Citations per year

Countries citing papers authored by Junwei Shi

Since Specialization
Citations

This map shows the geographic impact of Junwei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Shi more than expected).

Fields of papers citing papers by Junwei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junwei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Shi. The network helps show where Junwei Shi may publish in the future.

Co-authors

The 25 scholars most cited alongside Junwei Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junwei Shi Line = papers co-authored together Junwei Shi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#Work
1
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Hit paper breakdown →
20112419
2
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Hit paper breakdown →
20111587
3
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Hit paper breakdown →
2017901
4
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Hit paper breakdown →
2014748
5
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Hit paper breakdown →
2015587
6
Roles of arabidopsis WRKY18, WRKY40 and WRKY60 transcription factors in plant responses to abscisic acid and abiotic stress
Hit paper breakdown →
2010458
7 2013281
8 2018278
9 2018174
10 2021156
11 2016155
12 2021149
13 2012135
14 2019133
15 2018129
16 2016127
17 2021126
18 2015121
19 2018112
20 2013105

About Junwei Shi

Junwei Shi is a scholar working on Genetics, Hematology, Molecular Biology, Oncology and Immunology, having authored 95 papers that have together received 10.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Hemoglobinopathies and Related Disorders (14 papers), CRISPR and Genetic Engineering (11 papers), Protein Degradation and Inhibitors (10 papers), Chromatin Remodeling and Cancer (10 papers), Genomics and Chromatin Dynamics (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Molecular Biology (6.9k citations), Hematology (1.1k citations), Oncology (1.4k citations), Genetics (518 citations) and Cancer Research (523 citations). Junwei Shi has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Christopher R. Vakoc, Eric Wang, Joseph P. Milazzo, Scott Lowe, Justin B. Kinney, Johannes A. Zuber, James E. Bradner, Jun Qi, Christopher Johns and Amy Rappaport. Their work appears in journals such as Blood, Molecular Cell, Nature Communications, Nature Biotechnology and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact